The pathogenic role of anti-phosphatidylserine antibodies: Active immunization with the antibodies leads to the induction of antiphospholipid syndrome

被引:35
|
作者
Yodfat, O [1 ]
Blank, M [1 ]
Krause, I [1 ]
Shoenfeld, Y [1 ]
机构
[1] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
来源
关键词
D O I
10.1006/clin.1996.0003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary antiphospholipid syndrome (pAPS) can be experimentally induced in mice by immunization with anti-cardiolipin (aCL) antibodies (Abs), Recently, we have pointed to the pathogenic role of antiphosphatidylserine (aPS) Abs by inducing an experimental model of pAPS in naive mice following passive transfer of human aPS to the tail vein of ICR mice. The aim of the present study was to induce experimental pAPS in mice following active immunization with aPS, Mice were immunized with IgG and IgM aPS, purified from two patients with pAPS, The sera of the mice were examined for the presence of different antiphospholipid Abs, and the beta(2)GPI dependency of aPS, using an enzyme-linked immunosorbent assay (ELISA), Inhibition ELISA studies, with silica beads coated with phospholipids, were used to detect cross-reactivity of aPS or aCL to other phospholipids. The mice were also tested for the presence of thrombocytopenia, prolonged activated partial thromboplastin time (APTT), and the percentage of fetal resorptions. The purified IgG aPS but not IgM aPS had a strong lupus anticoagulant activity. Both IgG and IgM aPS were beta(2)GPI dependent and did not bind PS in the absence of the glycoprotein. The mice immunized with IgG aPS, but not IgM aPS, developed high titers of mouse aPS. The mice generated polyspecific Abs, cross-reacting with aCL and aPS, as well as individual aPS or aCL Abs. Only the mice immunized with IgG aPS developed clinical parameters of pAPS: prolonged APTT, thrombocytopenia, and an increased fetal resorption rate. In conclusion, active immunization with IgG, but not IgM, aPS induces experimental pAPS in naive mice, thus pointing to the participation of aPS in the idiotypic network. (C) 1996 Academic Press, Inc.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 50 条
  • [21] Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
    Zigon, Polona
    Pirkmajer, Katja Perdan
    Tomsic, Matija
    Kveder, Tanja
    Bozic, Borut
    Semrl, Snezna Sodin
    Cucnik, Sasa
    Ambrozic, Ales
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [22] Anti-Phosphatidylserine/Prothrombin Antibody Titers Are Strongly Correlated with Lupus Anticoagulant Assays in Patients with Antiphospholipid Antibodies
    Miyara, Makoto
    Arnaud, Laurent
    Dufat, Laurent
    Diemert, Marie-Claude
    Ankri, Annick
    Mathian, Alexis
    Haroche, Julien
    Boutin, Du
    Ghillani-Dalbin, Pascale
    Costedoat-Chalumeau, Nathalie
    Casas, Silvia
    Piette, Jean-Charles
    Musset, Lucile
    Amoura, Zahir
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S7 - S7
  • [23] Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome
    Sciascia, S.
    Bertolaccini, M. L.
    [J]. LUPUS, 2014, 23 (12) : 1309 - 1312
  • [24] Anti-phosphatidylserine antibodies and the risk of myocardial infarction and coronary death
    Manttari, M
    Puurunen, M
    Manninen, V
    Palosuo, T
    [J]. CIRCULATION, 1998, 98 (17) : 170 - 170
  • [25] Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?
    Pregnolato, Francesca
    Chighizola, Cecilia B.
    Encabo, Susan
    Shums, Zakera
    Norman, Gary L.
    Tripodi, Armando
    Chantarangkul, Veena
    Bertero, Tiziana
    De Micheli, Valeria
    Borghi, Maria Orietta
    Meroni, Pier Luigi
    [J]. IMMUNOLOGIC RESEARCH, 2013, 56 (2-3) : 432 - 438
  • [26] Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?
    Francesca Pregnolato
    Cecilia B. Chighizola
    Susan Encabo
    Zakera Shums
    Gary L. Norman
    Armando Tripodi
    Veena Chantarangkul
    Tiziana Bertero
    Valeria De Micheli
    Maria Orietta Borghi
    Pier Luigi Meroni
    [J]. Immunologic Research, 2013, 56 : 432 - 438
  • [27] The role of anti-phosphatidylserine/prothrombin antibodies in thrombotic manifestations of systemic lupus erythematosus patients
    Tselios, Konstantinos
    Sarantopoulos, Alexandros
    Gkougkourellas, Ioannis
    Boura, Panagiota
    [J]. FRONTIERS IN NEUROLOGY, 2013, 4
  • [28] INDUCTION OF ANTIPHOSPHOLIPID ANTIBODIES BY IMMUNIZATION WITH ANTICARDIOLIPIN COFACTOR
    SAMMARITANO, LR
    WEN, JY
    ELKON, KB
    GHARAVI, AE
    [J]. CLINICAL RESEARCH, 1991, 39 (03): : A659 - A659
  • [29] Anti-Phosphatidylserine/Prothrombin Antibodies (aPS/PT) As Potential Diagnostic Markers and Risk Predictors of Venous Thrombosis and Obstetric Complications in Antiphospholipid Syndrome
    Shi, Hui
    Hu, Qiongyi
    Zheng, Hui
    Teng, Jialin
    Norman, Gary
    Zhou, Jinfeng
    Yang, Chengde
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] Pathogenic role of antiphospholipid antibodies: an update
    Fujieda, Y.
    Amengual, O.
    Atsumi, T.
    [J]. LUPUS, 2018, 27 (13) : 2012 - 2013